… Our results show that striatal dopamine transporter uptake declines with increasing disability
in Parkinson's disease. Thus, [ 18 F]β-CFT is a useful ligand, not only in the diagnosis of …

… in vivo density of monoamine transporters, including the dopamine transporter (DAT). [ 11
C]β-CFT is useful for studying DAT as a marker of dopaminergic innervation in animal models …

… Dopaminergic neurotransmission is terminated by the activity of the presynaptic dopamine
transporter (DAT) that mediates the reuptake of extracellular dopamine (DA) into the cell, and …

… CFT binding to the striatal dopamine transporters in the Fischer 344 rats: a PET study[J]. Ann
… Dopamine transporter imaging agent 11C鄄CFT and 18F鄄CFT and its clinical application …

… No studies have previously been performed on dopamine transporter ligand … dopamine
transporter function with PET during the progression of PD using [18F]CFT18,19 dopamine …

… However, the messenger RNA for the dopamine transporter in … C]β-CFT uptake is not entirely
due to loss of nigral neurons. … of the dopamine reuptake ligand, [ 11 C]β-CFT, declines in …

… of dopaminergic system in the striatum of the patients with PD at different stages using CFT,
… Dopaminergic function and dopamine transporter binding assessed with positron emission …

… Reactivity of DAQ with Cys 90 increased the affinity of [ 3 H]β-CFT for the transporter, …
dopamine transporter (hDAT), using both wild-type and cysteine mutant constructs of this transporter…

… With [ 123 I]β-CIT SPECT, no significant difference among … of a dopamine transporter
PET ligand, [ 18 F]CFT, in … F]CFT uptake and the normal variation of test–retest [ 18 F]CFT …

… -CFT binding in the striatum in the present study is in accord with previous reports of dopamine
transporter … Specifically, the putaminal reduction in the -CFT binding was more prominent …